Adamantane, min.99%, pour la synthèse, 100 g, emballage en verre

2-Chloro-5,7-dimethyl-1,3-benzothiazole, 95.0%, 500mg

1-(3-isopropyl-4-methoxyphenyl)ethanone, 1g

METHYL 8-CHLOROIMIDAZO[1,2-A]PYRAZINE-2-CARBOXYLATE, 95.0%, 1g

1-Aminocyclopropane-1-carboxylic acid ethyl ester hydrochloride, 98.0%, 1g

Urea, N-6-isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]-, 25mg

1-Methyl-1H-pyrazole-4,5-diamine bis(sulfate), 100mg

Methyl 5-bromo-6-methylnicotinate, 97%, 100mg

3-Bromo-4-methoxy-1-methyl-1H-indazole, 95%, 100mg

3,5-Difluoro-2-(trifluoromethyl)pyridine, 97.0%, 250mg

3-(4-Methoxyphenyl)-5-(piperidin-3-yl)-1,2,4-oxadiazole hydrochloride, 98.0%, 250mg

Ethyl 3-(trifluoromethyl)benzoate, 97.0%, 25g

1-Phenyl-2,5,8,11-tetraoxatridecan-13-oic acid, 98%, 100mg